Scientific Advisory Board
Judith Campisi, Ph.D.
Senior Staff Scientist
U.C. Berkeley, Lawrence Berkeley National Laboratories
Dr. Campisi is a leading authority on telomerase, cellular senescence and the cell cycle.
http://www.lbl.gov/lifesciences/labs/campisi_lab.html
Joel Hedgpeth, Ph.D.
President, CEO, and Co-founder
CompleGen, Berlex Biosciences, Codon Corp.
Joel Hedgpeth founded Codon Corporation, a biotechnology company that was acquired by Schering, AG in 1990. He served as Vice President of Basic Research at Berlex Biosciences (a US subsidiary of Schering, AG) until 1993. Dr. Hedgpeth was acting Chief Scientific Officer of Epoch Biosciences (NASDQ; EBIO) until 2002. Dr. Hedgpeth received his degree with Herbert W. Boyer (founder of Genentech) at the University of California, San Francisco and after postdoctoral work at the University of Geneva, was a visiting professor at the Pasteur Institute (Paris) and a Research Fellow at the Howard Hughes Institute, UCSF.
Bryant Villeponteau, Ph.D.
Healthspan Sciences, Geron
While working with Dr. Andrews at Geron, Dr. Villeponteau shared the 1997 2nd place Inventor of the Year Award. Dr. Villeponteau is also an internationally recognized expert in the aging process caused by oxidative stress. Dr. Villeponteau served as President of Healthspan Sciences.
Federico Gaeta, Ph.D.
Geron, Cytel, Schering-Plough, Bristol Myers Squibb
Dr. Gaeta identified the first potent, small molecule, inhibitors of human telomerase. He is the sole inventor of universal therapeutic cancer vaccine technologies based on telomerase, currently being evaluated in human clinical trials. Dr. Gaeta is an experienced executive with major pharmaceutical and biotechnology companies in the area of new drug discovery and development.
